- 6 dentists making headlines
- Iowa hospital CEO to retire
- The biggest gap in OR performance — and how to address it
- Hospital primary palliative care linked to lower ICU admission, length of stay: 4 notes
- The Clinical Denial Surge: Why Your Business Office Needs an Artificial Intelligence “Clinician-Attorney” Hybrid
- The Clinical Denial Surge: Why Your Business Office Needs an Artificial Intelligence “Clinician-Attorney” Hybrid
- CHS to sell 9 hospitals for more than $1.2B
- Medical City Alliance taps new COO
- Cencora acquires EyeSouth Partners’ retina arm for $1.1B
- FDA to hold public hearing on drug voucher pilot
- Providence saves $2.3M through device reuse strategy
- 3 contenders for CDC’s top spot: Reports
- Where the ACA stands, 16 years in
- Where the ACA stands, 16 years in
- Children’s National launches division for pediatric AI research
- Best small cities for careers
- Orthopedic ASC proposed in Massachusetts
- Sutter-Allina deal pushes ambulatory growth strategy
- FTC launches healthcare task force
- Nearly 90,000 Bottles of Children’s Ibuprofen Recalled Nationwide
- Meet the CEOs, presidents leading the largest ASC companies
- Algunos adultos de mediana edad deciden posponer la atención médica hasta tener Medicare
- ¿Qué tan bajo se puede llegar? Las cambiantes guías para el control de la presión arterial
- Insmed sets up Arikayce for a significant label expansion on new ph. 3 data
- EyePoint lawsuit accuses Ocular of ‘malicious’ defamation campaign in retina drug race
- FDA mandates label updates to common Parkinson's meds based on seizure risk finding
- A Nasal Swab for Alzheimer's? Duke Team Has One in Testing
- Your Bank Account Might Show How Well Your Brain Will Age, Researchers Say
- Rural Residents Have Highest Cancer Death Rates, Researchers Say
- Insurance Lapses Play Havoc With Diabetes Management, Study Shows
- Psychedelics Aren't Better Than Antidepressants In Treating Depression, Review Concludes
- Heat Advisories Might Not Trigger Soon Enough For Some Seniors, Study Finds
- Dizal's Zegfrovy clinches landmark phase 3 win in NSCLC subtype, setting up challenge to J&J's Rybrevant
- Novartis joins Lilly, AZ in China expansion with $480M commitment to boost manufacturing, R&D
- Even With Dental Insurance, You Still Could Face a Large Bill
- Rising Health Costs Push Some Middle-Aged Adults To Skip the Doc Until Medicare
- FDA solicits feedback on controversial national priority voucher review pathway
- Health Tech Weekly Rundown: Perplexity rolls out AI-powered medical records search; Doximity survey examines how docs use AI
- Legisladores buscan proteger a los centros de crisis de embarazo mientras disminuye el número de clínicas de abortos
- Don't Forget This: Study Shows Cannabis Exacts a Toll on Your Memory
- Want To Stress Less? Start With These Everyday Habits
- Journalists Shine Light on Out-of-Reach Insurance Prices, AI’s Role in Claims Disputes, and Susie Wiles
- The explosion of the Medicare Advantage special needs plan
- North Star to cut additional jobs
- 6 Optum updates to know from Q1
- The shifting dental hygiene landscape
- 12 dental insurance updates in 30 days
- ‘The 1980s called’: CMS to phase out fax, mail
- This ASC startup is wiring AI into the fabric of outpatient surgery
- Intermountain plans new outpatient clinic
- Legacy Health, Regence BCBS face looming contract expiration
- Meet the COOs of the largest DSOs
- In the Affordability Alphabet Soup of the ACA and EHBs, a Link to Higher Premiums Isn’t Clear-Cut
- CMS final rule aims to axe the fax machine, phase out paper mailing
- 24 profitable health systems in 2025
- How 2 CFOs plan for uncertainty
- Heartland Dental expands with Texas affiliation
- SALT Dental Partners adds Washington practice
- 11 dental school updates to know
- 6 health systems seeking revenue cycle executive directors
- Remarks at The SEC Speaks in 2026: From Kitchen Table to Cap Table—Making Capital Formation Work for Small Businesses
- Heart Benefits From GLP-1 Drugs Fade After Stopping, Study Finds
- Survey Shows More People Struggling To Afford ACA Insurance
- Up to 155,000 COVID Deaths May Not Have Been Counted, Study Finds
- FDA Drops Plan To Ban Tanning Beds for Minors Nationwide
- Idaho bill proposes consolidating dental regulatory oversight
- Washington hospital charts path to preserve primary care
- 4 DSOs making headlines
- NYC Health + Hospitals names dentistry, oral surgery leaders
- Mindray North America Enters Ventilator Market
- Mindray North America Enters Ventilator Market
- LivaNova Receives FDA Premarket Approval for to treat Moderate to Severe Obstructive Sleep Apnea
- LivaNova Receives FDA Premarket Approval for to treat Moderate to Severe Obstructive Sleep Apnea
- Perfuze Receives FDA 510(k) Clearance for Millipede88 Aspiration Catheter
- Perfuze Receives FDA 510(k) Clearance for Millipede88 Aspiration Catheter
- EPA proposes new rule on Ethylene Oxide Emissions: Could Loosen Limits on Medical Device Sterilization
- EPA proposes new rule on Ethylene Oxide Emissions: Could Loosen Limits on Medical Device Sterilization
- With Novo's semaglutide going off patent, Indian drugmakers set to launch their cheaper generics
- Sanofi backs 2 more documentary films about rare blood disorders
- ACIP member's miscommunication on vaccine panel's future adds to confusion after court ruling
- Rhythm's Imcivree scores 'transformative' FDA approval in brain damage-related obesity
- Some Patients With ADHD and Addiction History Missing Out
- Social Media Poses Risks to Children's Mental Health, Review Concludes
- 'Early Bird' Exercisers Get The Most Health Benefits, Study Finds
- Does Closing Your Eyes Help You Hear Better?
- High Blood Pressure Deaths Quadruple Among Young Women, Study Finds
- Meningitis Vaccine Doesn't Protect Gay, Bisexual Men From Gonorrhea, Clinical Trial Concludes
- Oz Escalates Medicaid Fraud Claims Against States After Focus on Minnesota
- ‘How Low Can You Go?’ The Shifting Guidelines for Blood Pressure Control
- Listen: Trump’s NIH ‘Reset’ Is Driving Away Scientists
- Verily banks $300M to accelerate AI road map, transitions to independent company
- KFF: ACA plan enrollees report rising costs for 2026 coverage
- Industry Voices—Stop buying AI tools, start designing AI architecture
- CSL warns of supply shortfall, treatment delays for hemophilia gene therapy Hemgenix
- 10K Corewell Health nurses vote to authorize labor strike
- Providence mulling sale of its health plan amid financial pressures
- Fierce Pharma Asia—World's 1st brain chip nod; AZ's cell therapy bet; Astellas-CytomX breakup
- Gut Microbiome May Take Years to Recover From Antibiotic Use
- Prepared Remarks Before SEC Speaks
- The Art and Science of Materiality
- Capital, Choice, and the Pursuit of Happiness: Remarks at The SEC Speaks in 2026
- Novo's Wegovy HD passes muster under FDA national priority voucher program
- Hospital operations begin 2026 with depressed margins amid low volumes, high labor spend
- The Math Behind Eczema Flare-Ups May Finally Add Up
- Male preconception startup Upstream announces donor-matching platform
- Women's health sector could grow to $600B industry by 2030: PwC report
- Democratic senators detail plans to take on 'Big Insurance'
- PrescriberPoint's solution to the modern prescribing journey
- Both Types Of Diabetes Increase Dementia Risk
- Aldi Recalls Spinach Bites Over Possible Contamination
- Collegium ponies up $650M to gain ADHD drug Azstarys from Corium
- Maryland bill calls for more transparency in pharma's disease awareness campaigns
- After Alfasigma's GSK licensing deal, Lynavoy picks up FDA nod in rare liver disease
- What To Know About Fatty Liver Disease and Why It’s So Common
- Drug Smoking Linked To Surge In Severe Burn Cases
- Thymus Gland Health May Be Key to Long Life and Fighting Cancer
- Premature Menopause Increases Heart Disease Risk
- U.S. Teen Obesity Hits Record Highs While Efforts to Slim Down Drop
- Pesticide Exposure Before Pregnancy Might Risk Newborn Health
- UPDATED: AstraZeneca to build cell therapy manufacturing hub, R&D center in Shanghai
- How CVS Caremark Is Shaping the Future of Pharmacy Benefits
- CDMO Axplora to pump $60M into Italian complex API plant
- Pfizer eyes earlier Talzenna use after phase 3 prostate cancer win
- Prodeon Medical FDA 510(k) approved for the Urocross Expander System, a Non-Permanent Retrievable Implant for Treating Benign Prostatic Hyperplasia
- Prodeon Medical FDA 510(k) approved for the Urocross Expander System, a Non-Permanent Retrievable Implant for Treating Benign Prostatic Hyperplasia
- JenaValve Gets FDA Nod for Trilogy Transcatheter Heart Valve (THV) to Treat Aortic Regurgitation (ssAR)
- JenaValve Gets FDA Nod for Trilogy Transcatheter Heart Valve (THV) to Treat Aortic Regurgitation (ssAR)
- Turquoise Health raises $40M to power healthcare contracts, payments
- To tackle healthcare costs, representatives weigh curbs on provider consolidation
- A look at Highmark's specialty pharmacy partnership with Free Market Health
- AD/PD 2026: New data highlight potential cost-effectiveness of confirmatory AD blood testing in U.S. diagnostic pathways
- With downgrade, HSBC casts doubt about Lilly's 'stairway to heaven' trajectory
- TrumpRx's 'world's lowest' drug price claims fall short in global comparison: NYT
- Beyond payment integrity: An AI-driven approach to affordability
- Study Finds Little Proof Cannabis Helps Most Mental Health Conditions
- Meningitis Outbreak Tied to Students Leaves 2 Dead and 11 Sick in England
- Belly Fat Linked To Heart Failure Risk
- Women More Likely To Survive Cancer Than Men — At A Cost
- healow Genie AI Contact Center Helped Manage 76% of Calls—Demonstrating That Patient Access and Operational Efficiency Go Together
- Ultra-Processed Foods Linked To Heart Attack, Stroke, Cardiac Arrest
- E. Coli Outbreak Tied To Raw Cheddar Cheese Sickens 7 People
- The Sunshine Vitamin and COVID: New Study Finds Mixed Results for Recovery
- Too Much Smartphone Use Linked to Disordered Eating in Teens
- Shingles Vaccine Protects Heart Failure Patients From Heart Attack, Stroke
- White House Chief of Staff Susie Wiles Diagnosed With Early Breast Cancer
- AI is Transforming MLR—but Flexibility is What Will Make it Work
- Regulation Crypto Assets: A Token Safe Harbor
- The Last Chapter in the Book of Howey
- Payers, hospitals pan CMS' plan to bring non-network plans to ACA exchanges
- Optum Real and Suki build out collaboration to tackle payment challenges as R1 teams with AI scribe Heidi
We used to think it was bad that IV pumps reset when visitors ignored "No cell phones" warnings. Healthcare Brew reports today's evolved version of the problem.
https://www.healthcare-brew.com/stories/2025/06/10/recalled-ventilator-easy-hack
Recalled ventilator was so easy to hack, ‘a teenager’ could have done it
‘Secure by design’ isn’t just a tech buzzword.
By Caroline Catherman | June 10, 2025There’s a cybersecurity problem breathing down the healthcare industry’s neck.
On April 7, Baxter Healthcare pulled all 4,100+ Welch Allyn Life2000 ventilators due to severe cybersecurity concerns. The FDA labeled this a Class I recall, meaning these issues threatened patients’ lives, though the agency hasn’t reported any injuries or deaths.
Naomi Schwartz, a former FDA employee and VP of services for MedCrypt, a cybersecurity firm for medical device manufacturers, told Healthcare Brew this recall should be a lesson for the medical technology industry.
This is one of several device recalls in recent years prompted by cybersecurity concerns, and in her opinion, Baxter did the right thing fast. The global medtech company first flagged these weaknesses in November, noting that there hadn’t been any hacks up to that point. An April market removal is a relatively short turnaround, she added.
But the vulnerabilities were easily avoidable with a development framework known as secure by design, the idea that companies—not consumers—are responsible for cybersecurity, and products should have features like multi-factor authentication.
The issues. On a scale of “you have to have a PhD” to “a teenager” could hack the system, Baxter’s ventilator security was more toward the latter, Schwartz said. Let’s run through some of the issues:
- No encryption. For one, the ventilators didn’t encrypt sensitive information, like passwords, according to Baxter’s November security advisory. “If I’m just issuing all my data in plain text, that’d be like me sending you an email saying, ‘Hey, my front door is unlocked. Walk into my house, why don’t you?’” Schwartz said.
- Physical ports. All a hacker needed to do to access the device was walk into a hospital and plug a piece of hardware into a physical port on the ventilator, Schwartz explained.
- Few authentication requirements. The software used to test and calibrate the ventilators didn’t require authentication from the user either, so anyone could have tweaked the ventilator settings. This flaw was severe enough to earn a score of 10/10 on a scale used by the government to measure vulnerabilities—“a nightmare scenario,” Schwartz said.
Learning opportunities. These issues should prompt other companies to double-check their own ventilators’ security—especially legacy devices that were made many years ago, Schwartz said.“These are very common problems, and they’re all things that a secure-by-design set of practices would have prevented,” she said.
The good news is Schwartz thinks Baxter responded quickly and appropriately once it discovered these flaws.
“The people out there who are producing and selling these products are doing their due diligence. They’re going back and checking older systems. They’re making sure that things are good and secure, and when they’re not, they’re taking appropriate action,” she said.
This incident comes after the FDA and Congress have ramped up medical device cybersecurity requirements in recent years.
For instance, in March 2023, the Protecting and Transforming Cyber Healthcare Act started requiring medical device manufacturers to address cybersecurity requirements in their submissions for market approval.
Get MHF Insights
News and tips for your healthcare freedom.
We never spam you. One-step unsubscribe.














